Immunomodulatory role of high-density lipoproteins: impact on immunosenescence

Age

Volumn 36, Issue 5, 2014, Pages

  Larbi, Anis ^a   Fortin, Carl ^b   Dupuis, Gilles ^b   Berrougui, Hicham ^b   Khalil, Abdelouahed ^b   Fulop, Tamas ^b  

^a AGENCY FOR SCIENCE   (Singapore)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Aging; HDL; Immunosenescence; Inflamm Aging; Metabolic pathways

Indexed keywords

ABC TRANSPORTER A1; C REACTIVE PROTEIN; CD27 ANTIGEN; CD28 ANTIGEN; CD45RA ANTIGEN; CHOLESTEROL; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE LCK; SCAVENGER RECEPTOR BI; T LYMPHOCYTE RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN RECEPTOR;

AGE; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEMBRANE FLUIDITY; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSENESCENCE; INTRACELLULAR SIGNALING; LIPID COMPOSITION; LIPID RAFT; LIPID STORAGE; LYMPHOCYTE MEMBRANE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPOIESIS; MALE; MOLECULAR DYNAMICS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; ADULT; AGING; CELLULAR IMMUNITY; FLOW CYTOMETRY; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGING; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOMODULATION; LIPID METABOLISM; LIPOPROTEINS, HDL; MALE; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84919754842     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-014-9712-6     Document Type: Article

References (51)

1. Badimon L, Vilahur G (2012) LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Ann N Y Acad Sci 1254:18–32
2. Berrougui H, Khalil A (2009) Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity. Rejuvenation Res 12:117–26
3. Berrougui H, Isabelle M, Cloutier M, Grenier G, Khalil A (2007) Age-related impairment of HDL-mediated cholesterol efflux. J Lipid Res 48:328–36
4. Berrougui H, Grenier G, Loued S, Drouin G, Khalil A (2009) A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis 207:420–7
5. Borba EF, Carvalho JF, Bonfá E (2006) Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin Dev Immunol 13:203–208
6. Carpintero R, Gruaz L, Brandt KJ, Scan A, Faill D, Combes V, Grau GE, Burger D (2010) HDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production. PLoS One 5:e11869
7. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC (1986) Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 261:9644–9651
8. de Mello CV, Nguyen D, Giri B, Bunbury A, Schaffer E, Taub DD (2004) Quantitative differences in lipid raft components between murine CD4+ and CD8+ T cells. BMC Immunol 5:2
9. Di Mitri D, Azevedo RI, Henson SM, Libri V, Riddell NE, Macaulay R, Kipling D, Soares MV, Battistini L, Akbar AN (2011) Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol 187:2093–2100
10. Douziech N, Seres I, Larbi A, Szikszay E, Roy PM, Arcand M, Dupuis G, Fulop T (2002) Modulation of human lymphocyte proliferative response with aging. Exp Gerontol 37:369–87
11. Fortin CF, Larbi A, Lesur O, Douziech N, Fulop T (2006) Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J Leukoc Biol 79:1061–72
12. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
13. Fülöp T, Gagné D, Goulet AC, Desgeorges S, Lacombe G, Arcand M, Dupuis G (1999) Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex. Exp Gerontol 34:197–216
14. Fülöp T, Douziech N, Goulet AC, Desgeorges S, Linteau A, Lacombe G, Dupuis G (2001) Cyclodextrin modulation of T lymphocyte signal transduction with aging. Mech Ageing Dev 122:1413–1430
15. Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, Pawelec G (2005) Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 22:589–603
16. Fülöp T, Le Page A, Garneau H, Azimi N, Baehl S, Dupuis G, Pawelec G, Larbi A (2012) Aging, immunosenescence and membrane rafts: the lipid connection. Longevity and Healthspan. MS ID: 1582891234741859
17. Fülöp T, Larbi A, Pawelec G (2013) Human T cell aging and the impact of persistent viral infections. Front Immunol 4:271
18. Fulop T, Le Page A, Fortin C, Witkowski JM, Dupuis G, Larbi A (2014) Cellular signaling in the aging immune system. Curr Opin Immunol 29C:105–111
19. Goronzy JJ, Li G, Yu M, Weyand CM (2012) Signaling pathways in aged T cells—a reflection of T cell differentiation, cell senescence and host environment. Semin Immunol 24:365–372
20. Gruaz L, Delucinge-Vivier C, Descombes P, Dayer JM, Burger D (2010) Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes. PLoS One 5:e9418
21. Jaouad L, de Guise C, Berrougui H, Cloutier M, Isabelle M, Fulop T, Payette H, Khalil A (2006) Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1’s free sulfhydryl groups. Atherosclerosis 185:191–200
22. Kabouridis PS (2006) Lipid rafts in T cell receptor signalling. Mol Membr Biol 23:49–57
23. Katsanidis E, Addis PB (1999) Novel HPLC analysis of tocopherols, tocotrienols, and cholesterol in tissue. Free Radic Biol Med 27:1137–1140
24. Khalil A, Berrougui H, Pawelec G, Fulop T (2012) Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer’s disease. Mech Ageing Dev 133:20–29
25. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127–135
26. Landry YD, Denis M, Nandi S, Bell S, Vaughan AM, Zha X (2006) ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem 281:36091–36101
27. Larbi A, Dupuis G, Douziech N, Khalil A, Fulop T (2004a) Low-grade inflammation with aging has consequences for T-lymphocyte signaling. Ann NY Acad Sci 2004(1030):125–133
28. Larbi A, Douziech N, Dupuis G, Khalil A, Pelletier Guerard KP, Fülöp T (2004b) Age-associated alterations in the recruitment of signal-transduction proteins to lipid rafts in human T lymphocytes. J Leukoc Biol 75:373–381
29. Larbi A, Douziech N, Khalil A, Dupuis G, Gheraïri S, Guérard KP, Fülöp T (2004c) Effects of methyl-beta-cyclodextrin on T lymphocytes lipid rafts with aging. Exp Gerontol 39:551–558
30. Larbi A, Dupuis G, Khalil A, Douziech N, Fortin C, Fülöp T (2006a) Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell Signal 18:1017–1030
31. Larbi A, Muti E, Giacconi R, Mocchegiani E, Fülöp T (2006b) Role of lipid rafts in activation-induced cell death: the fas pathway in aging. Adv Exp Med Biol 584:137–155
32. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G (2008) Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 23:64–74
33. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ, Fulop T (2011) Impact of age on T cell signaling: a general defect or specific alterations? Ageing Res Rev 10:370–378
34. Larbi A, Rymkiewicz P, Asudev A, Low I, Shadan BN, Mustafah S et al (2013) The immune system in the elderly: a fair fight against diseases. Aging Health 9:1–13
35. Le Page A, Fortin C, Garneau H, Allard N, Tsvetkova K, Tan CT, Larbi A, Dupuis G, Fülöp T (2014) Downregulation of inhibitory SRC Homology 2 Domain-containing Phosphatase-1 (SHP-1) leads to recovery of T cell responses in elderly. Cell Commun Signal 9 12(1):2
36. Lighart GH (2001) The SENIEUR protocol after 16 years: the next step is to study the interaction of ageing and disease. Mech Ageing Dev 122:136–140
37. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–217
38. Maczek C, Bock G, Jurgens G, Schonitzer D, Dietrich H, Wick G (1998) Environmental influence on age-related changes of human lymphocyte membrane viscosity using severe combined immunodeficiency mice as an in vivo model. Exp Gerontol 33:485–498
39. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D, Chin-Dusting J (2008) High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28:2071–2077
40. Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, Sviridov D, Chin-Dusting JP (2011) Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 31:1333–1341
41. Norata GD, Pirillo A, Catapano AL (2011) HDLs, immunity, and atherosclerosis. Curr Opin Lipidol 22:410–416
42. Norata GD, Pirillo A, Ammirati E, Catapano AL (2012) Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 220:11–21
43. Park KH, Cho KH (2011) High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx. J Gerontol A Biol Sci Med Sci 66:511–520
44. Pawelec G (2012) Hallmarks of human “immunosenescence”: adaptation or dysregulation? Immun Ageing 9:15
45. Perrin-Cocon L, Diaz O, Carreras M, Dollet S, Guironnet-Paquet A, André P, Lotteau V (2012) High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation. Immunobiology 217:91–99
46. Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C (2004) Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 39:629–35
47. Reichardt P, Dornbach B, Gunzer M (2010) APC, T cells, and the immune synapse. Curr Top Microbiol Immunol 340:229–249
48. Sattler W, Mohr D, Stocker R (1994) Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol 233:469–489
49. Simons K, Gerl MJ (2010) Revitalizing membrane rafts: new tools and insights. Nature Rev Mol Cell Biol 11:688–699
50. Simons K, Sampaio JL (2011) Membrane organization and lipid rafts. Cold Spring Harb Perspect Biol 3:a004697
51. Wang SH, Yuan SG, Peng DQ, Zhao SP (2012) HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. Atherosclerosis 225:105–114